Good News / Press Release – COVID-19 re: Psoriasis patients on Biologics The Impact of COVID-19 Pandemic on Patients With Chronic Plaque Psoriasis Being Treated With Biologic Therapy The British Journal of Dermatology May 12 2020 LINK “TAKE-HOME MESSAGE The authors performed a retrospective analysis between February 20 and April 1, 2020, to determine the rate of hospitalization and death from COVID-19 in patients with psoriasis. Of 5206 Italian patients with plaque psoriasis on biologic therapy, 4 were hospitalized for COVID-19–related interstitial pneumonia. No patients died from the disease. Another 2 patients tested positive for COVID-19 but did not require hospitalization. In this limited study, it does not appear that patients on biologic therapy for chronic plaque psoriasis are at an increased risk for infection or worse outcomes related to COVID-19 than the general population.” – Caitlyn T. Reed, MD

Thanks for posting that……What is not clear is how many of the 5206 Biologics patients actually contracted Covid 19……anyway, such a low number hospitalised is encouraging and if taking biologics was a large risk in determining a poor outcome, certainly it would be expected that hospitalisation for Covid 19 patients taking biologics would be higher.